Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia

NCT00099996 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3

Enrollment

NIH

Sponsor class

Conditions

Heart Diseases
Metabolism, Inborn Errors

Interventions

DRUG: SCH-58235
DRUG: Ezetimibe

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)